You just read:

ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)

News provided by

ViroPharma Incorporated

Mar 29, 2011, 10:54 ET